These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18663939)

  • 1. [Optimization of the treatment and prevention of thrombus formation in arterial hypertension].
    Tolstopiatov SM; Naumenko LE
    Lik Sprava; 2007; (7):60-7. PubMed ID: 18663939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ukrainian break-through in the European and world strategy of individual prophylaxis of ischemic stroke in patients with arterial hypertension].
    Tolstopiatov SM
    Lik Sprava; 2010; (5-6):3-21. PubMed ID: 21488364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Module of hypercoagulation as a biomarker for estimation of hemostasis risk factor of thrombosis, determination of an individual antiaggregant dose and the way of its use in patients with arterial hypertension].
    Tolstopiatov SM
    Lik Sprava; 2007; (8):47-60. PubMed ID: 18712096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pilote strategy to optimize an individual treatment of arterial hypertention and algorithm of the prophylactics of vascular complications].
    Tolstopiatov SM
    Lik Sprava; 2006 Dec; (8):21-34. PubMed ID: 17427421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between biomarkers of the coagulation cascade, fibrinolytic system and lipid profiles in hypertensive patients with various coagulation potential of whole blood].
    Tolstopiatov SM
    Lik Sprava; 2009; (7-8):32-40. PubMed ID: 20455445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular smooth muscle cells are responsible for a prothrombotic phenotype of spontaneously hypertensive rat arteries.
    Ait Aissa K; Lagrange J; Mohamadi A; Louis H; Houppert B; Challande P; Wahl D; Lacolley P; Regnault V
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):930-7. PubMed ID: 25722431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention.
    Haus E
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):966-84. PubMed ID: 17822804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does hypertension confer a hypercoagulable state?
    Lip GY; Li-Saw-Hee FL
    J Hypertens; 1998 Jul; 16(7):913-6. PubMed ID: 9794730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in pharmacotherapy of thrombosis.
    Labuzek K; Krysiak R; Okopien B; Herman ZS
    Pol J Pharmacol; 2003; 55(4):523-33. PubMed ID: 14581710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The coagulation cascade--clinical implications].
    Langer H; Gawaz M
    Herz; 2005 May; 30(3):170-5. PubMed ID: 15902366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
    Remková A; Kratochvíl'ová H; Durina J
    J Hum Hypertens; 2008 May; 22(5):338-45. PubMed ID: 18305548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal platelet activation profile in patients with peripheral arterial disease on aspirin.
    van Geffen JP; Kleinegris MC; Verdoold R; Baaten CC; Cosemans JM; Clemetson KJ; Ten Cate H; Roest M; de Laat B; Heemskerk JW
    Thromb Res; 2015 Mar; 135(3):513-20. PubMed ID: 25600441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prothrombotic state in hypertension and the effects of antihypertensive treatment.
    Nadar S; Lip GY
    Curr Pharm Des; 2003; 9(21):1715-32. PubMed ID: 12871204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to inhibiting platelets and coagulation.
    Depta JP; Bhatt DL
    Annu Rev Pharmacol Toxicol; 2015; 55():373-97. PubMed ID: 25562644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and the prothrombotic state.
    Lip GY
    J Hum Hypertens; 2000; 14(10-11):687-90. PubMed ID: 11095159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.
    Jennings DL; Weeks PA
    Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of intracardiac thrombi by various imaging techniques and activation of platelets and coagulation-fibrinolysis in patients with cardioembolic stroke].
    Uchiyama S; Yamazaki M; Iwata M; Maruyama S
    Rinsho Shinkeigaku; 1996 Mar; 36(3):429-35. PubMed ID: 8741345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.